» Articles » PMID: 20667570

Recombinant Human Parainfluenza Virus Type 2 with Mutations in V That Permit Cellular Interferon Signaling Are Not Attenuated in Non-human Primates

Abstract

The HPIV2 V protein inhibits type I interferon (IFN) induction and signaling. To manipulate the V protein, whose coding sequence overlaps that of the polymerase-associated phosphoprotein (P), without altering the P protein, we generated an HPIV2 virus in which P and V are expressed from separate genes (rHPIV2-P+V). rHPIV2-P+V replicated like HPIV2-WT in vitro and in non-human primates. HPIV2-P+V was modified by introducing two separate mutations into the V protein to create rHPIV2-L101E/L102E and rHPIV2-Delta122-127. In contrast to HPIV2-WT, both mutant viruses were unable to degrade STAT2, leaving virus-infected cells susceptible to IFN. Neither mutant, nor HPIV2-WT, induced significant amounts of IFN-beta in infected cells. Surprisingly, neither rHPIV2-L101E/L102E nor rHPIV2-Delta122-127 was attenuated in two species of non-human primates. This indicates that loss of HPIV2's ability to inhibit IFN signaling is insufficient to attenuate virus replication in vivo as long as IFN induction is still inhibited.

Citing Articles

Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.

Audsley M, Moseley G World J Virol. 2013; 2(2):57-70.

PMID: 24175230 PMC: 3785049. DOI: 10.5501/wjv.v2.i2.57.


The V protein of Tioman virus is incapable of blocking type I interferon signaling in human cells.

Caignard G, Lucas-Hourani M, Dhondt K, Labernardiere J, Petit T, Jacob Y PLoS One. 2013; 8(1):e53881.

PMID: 23342031 PMC: 3544715. DOI: 10.1371/journal.pone.0053881.


Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium.

Schaap-Nutt A, Liesman R, Bartlett E, Scull M, Collins P, Pickles R Virology. 2012; 433(2):320-8.

PMID: 22959894 PMC: 3469718. DOI: 10.1016/j.virol.2012.08.027.


Pathogenesis of acute respiratory illness caused by human parainfluenza viruses.

Schomacker H, Schaap-Nutt A, Collins P, Schmidt A Curr Opin Virol. 2012; 2(3):294-9.

PMID: 22709516 PMC: 3514439. DOI: 10.1016/j.coviro.2012.02.001.


The C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining Stat1 in perinuclear aggregates at the late endosome.

Schomacker H, Hebner R, Boonyaratanakornkit J, Surman S, Amaro-Carambot E, Collins P PLoS One. 2012; 7(2):e28382.

PMID: 22355301 PMC: 3280236. DOI: 10.1371/journal.pone.0028382.


References
1.
Andrejeva J, Young D, Goodbourn S, Randall R . Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J Virol. 2002; 76(5):2159-67. PMC: 153821. DOI: 10.1128/jvi.76.5.2159-2167.2002. View

2.
Gottlieb J, Schulz T, Welte T, Fuehner T, Dierich M, Simon A . Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation. 2009; 87(10):1530-7. DOI: 10.1097/TP.0b013e3181a4857d. View

3.
Whitehead S, Bukreyev A, Teng M, Firestone C, St Claire M, Elkins W . Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J Virol. 1999; 73(4):3438-42. PMC: 104109. DOI: 10.1128/JVI.73.4.3438-3442.1999. View

4.
Ling Z, Tran K, Teng M . Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol. 2009; 83(8):3734-42. PMC: 2663251. DOI: 10.1128/JVI.02434-08. View

5.
McAuliffe J, Surman S, Newman J, Riggs J, Collins P, Murphy B . Codon substitution mutations at two positions in the L polymerase protein of human parainfluenza virus type 1 yield viruses with a spectrum of attenuation in vivo and increased phenotypic stability in vitro. J Virol. 2004; 78(4):2029-36. PMC: 369445. DOI: 10.1128/jvi.78.4.2029-2036.2004. View